Skip to main content
John Strickler, MD, Oncology, Durham, NC, Duke University Hospital

JohnHStricklerMD

Oncology Durham, NC

Gastrointestinal Cancer, Hematologic Oncology

Medical Oncology at Duke University

Dr. Strickler is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Strickler's full profile

Already have an account?

Education & Training

  • Duke University Hospital
    Duke University HospitalFellowship, Hematology and Medical Oncology, 2008 - 2011
  • University of Washington
    University of WashingtonResidency, Internal Medicine, 2006 - 2008
  • University of Washington
    University of WashingtonInternship, Internal Medicine, 2005 - 2006
  • University of Chicago Division of the Biological Sciences The Pritzker School of Medicine
    University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2005

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2008 - 2025
  • VA State Medical License
    VA State Medical License 2009 - 2011
  • WA State Medical License
    WA State Medical License 2005 - 2008
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Anti-EGFR Resistant Clones Decay Exponentially After Progression: Implications for Anti-EGFR Re-Challenge  
    B Kee, N Garg, M J Overman, V K Morris, B Johnson, J Wu, J H Strickler, S Kopetz, X Liu, D S Hong, Annals of Oncology

Press Mentions

  • Georgia Man Is Proof of Increasing Cases of Advanced Colorectal Cancer
    Georgia Man Is Proof of Increasing Cases of Advanced Colorectal CancerMarch 31st, 2023
  • Tucatinib and Trastuzumab Combination Approved for Advanced Colorectal Cancer
    Tucatinib and Trastuzumab Combination Approved for Advanced Colorectal CancerFebruary 10th, 2023
  • Colorectal Cancer: Why Some People May Be Able to Delay Regular Colonoscopies
    Colorectal Cancer: Why Some People May Be Able to Delay Regular ColonoscopiesJanuary 22nd, 2023
  • Join now to see all

Professional Memberships

Hospital Affiliations